In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

Legos will take over from Roger Dansey, who will begin transitioning to retirement. Pfizer announced that it has appointed Jeffrey Legos, PhD, MBA, as its new chief oncology officer, succeeding Roger ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while ...

So I think there probably is some risk to that," said Jeff Jonas, portfolio manager for Gabelli Funds, which held about $50 million of Pfizer shares as of September. Analysts expect earnings of 47 ...

However, at least two conditions listed as adverse events also appeared in Pfizer's 2024 list of genuine side effects. In January 2025, Snopes readers asked us about the authenticity of a long ...

An oncology-focused Pfizer is poised to grow over the coming years. Abundant (and growing) earnings protect the dividend despite an abnormally high yield. The stock's valuation signals that the ...

Pfizer on Wednesday named a longtime Novartis executive the leader of an oncology division it is leaning on to win back the support of investors in the years ahead. The pharmaceutical giant said ...

New York: Pfizer Inc. has announced that Jeffrey Legos, PhD, MBA, will join the company as Chief Oncology Officer. In this role, Dr. Legos will be responsible for leading the company’s Oncology ...

President Donald Trump's return to the White House could clear the way for the public to finally see a glimpse of Jeffrey Epstein's long-awaited "black book," as questions about the deceased ...